Shares of R1 RCM Inc (NASDAQ:RCM) have received an average broker rating score of 2.00 (Buy) from the two analysts that cover the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a hold recommendation and one has assigned a strong buy recommendation to the company. R1 RCM’s rating score has improved by 14.2% from 90 days ago as a result of various analysts’ ratings changes.

Brokers have set a 1-year consensus target price of $4.75 for the company and are expecting that the company will post $0.01 earnings per share for the current quarter, according to Zacks. Zacks has also given R1 RCM an industry rank of 122 out of 265 based on the ratings given to related companies.

A number of analysts recently weighed in on the stock. Zacks Investment Research upgraded shares of R1 RCM from a “strong sell” rating to a “hold” rating in a research report on Wednesday, October 4th. Robert W. Baird restated a “hold” rating and set a $5.00 target price on shares of R1 RCM in a report on Tuesday, September 26th.

Shares of R1 RCM (NASDAQ:RCM) opened at $4.37 on Wednesday. R1 RCM has a 52-week low of $2.02 and a 52-week high of $4.58.

A number of hedge funds have recently made changes to their positions in RCM. Paradigm Capital Management Inc. NY grew its stake in shares of R1 RCM by 14.8% during the 3rd quarter. Paradigm Capital Management Inc. NY now owns 6,967,900 shares of the financial services provider’s stock worth $25,851,000 after acquiring an additional 900,753 shares in the last quarter. Vanguard Group Inc. bought a new position in shares of R1 RCM during the 2nd quarter worth approximately $10,550,000. State Street Corp bought a new position in shares of R1 RCM during the 2nd quarter worth approximately $5,327,000. Northern Trust Corp grew its stake in shares of R1 RCM by 46.4% during the 2nd quarter. Northern Trust Corp now owns 1,145,411 shares of the financial services provider’s stock worth $4,295,000 after acquiring an additional 362,773 shares in the last quarter. Finally, AJO LP bought a new position in shares of R1 RCM during the 2nd quarter worth approximately $3,090,000. Hedge funds and other institutional investors own 47.63% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Analysts Anticipate R1 RCM Inc (RCM) to Announce $0.01 EPS” was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://www.watchlistnews.com/analysts-anticipate-r1-rcm-inc-rcm-to-announce-0-01-eps/1773776.html.

About R1 RCM

R1 RCM Inc, formerly Accretive Health, Inc, is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers.

Get a free copy of the Zacks research report on R1 RCM (RCM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.